Driving lipid metabolic reprogramming and immunosuppression through MIF-(CD74+CD44)-mediated macrophage polarization, our work finds FOS as a master regulator of the malignant C0 MAFF+ tumor cell subtype in LUAD. This evidence concerns the gene FOS and neoplasm.